All Pharma News
23andMe to Present 23ME-00610 Efficacy & Biomarker Data at ASCO 2024

23andMe to Present 23ME-00610 Efficacy & Biomarker Data at ASCO 2024
GLOBENEWSWIRE
24 Apr 2024
Share Share
23andMe announces CEO`s intention to pursue a potential take-private

23andMe announces CEO`s intention to pursue a potential take-private
GLOBENEWSWIRE
18 Apr 2024
Share Share
23andMe`s CEO files plan to take company private

23andMe`s CEO files plan to take company private
Ngai Yeung ENDPTS
18 Apr 2024
Share Share
23andMe to Present Data at AACR Annual Meeting 2024

23andMe to Present Data at AACR Annual Meeting 2024
GLOBENEWSWIRE
05 Apr 2024
Share Share
23andMe Initiates Ph1 Trial for its Dual MOA, 23ME-01473, Targeting ULBP6

23andMe Initiates Ph1 Trial for its Dual MOA, 23ME-01473, Targeting ULBP6
GLOBENEWSWIRE
20 Mar 2024
Share Share
23&Me Launches New Feature Connecting Customers to Historical Individuals

23&Me Launches New Feature Connecting Customers to Historical Individuals
GLOBENEWSWIRE
19 Mar 2024
Share Share
23andMe Launches New Genetic Reports on Common Forms of Cancer

23andMe Launches New Genetic Reports on Common Forms of Cancer
GLOBENEWSWIRE
06 Mar 2024
Share Share
23andMe Announces Presentations from Clinical-Stage Immuno-Oncology Programs

23andMe Announces Presentations from Clinical-Stage Immuno-Oncology Programs
GLOBENEWSWIRE
05 Mar 2024
Share Share
23andMe Reports Third Quarter Fiscal 2024 Financial Results

23andMe Reports Third Quarter Fiscal 2024 Financial Results
GLOBENEWSWIRE
07 Feb 2024
Share Share
23andMe Announces FDA Clearance of IND Application for 23ME-01473

23andMe Announces FDA Clearance of IND Application for 23ME-01473
GLOBENEWSWIRE
31 Jan 2024
Share Share